Meet our CEO in LSX World Congress 2024!

Meet our CEO Mikael Maksimow  in the LSX World Congress in London on 29-30 April 2024! We are raising funding to enter the clinical development phase with our SAR003  which is a novel targeted therapy for the treatment of GIST and other soft tissue sarcoma subtypes with very high unmet medical need!